In the spring of 2026, information recirculated of detailed summary of claims by Dr. Robert Malone. Drawing on what he described as 41 primary declassified sources, Malone alleged that U.S. military and intelligence programs in the 1950s–1970s released hundreds of thousands of radioactive ticks, conducted open-air experiments involving infected arthropods, and that containment failures at facilities such as Plum Island Animal Disease Center contributed to the emergence of Lyme disease and related tick-borne illnesses along the Northeast corridor. The post listed Operation Mongoose tick drops on Cuba, Project 112 bioweapons tests, Operation Big Itch flea releases, and the later suppression of co-infection data by Willy Burgdorfer, the scientist who identified the Lyme bacterium.
These claims are not new. They have circulated for years in books, congressional inquiries, and online discussions. Mainstream infectious-disease researchers and institutions have repeatedly rejected a laboratory origin for Lyme disease, pointing to molecular evidence that Borrelia burgdorferi circulated in North American wildlife decades before the relevant facilities became active, and noting that the bacterium makes a poor bioweapon due to its slow transmission and low mortality.Medpagetoday
Yet the news rapid spread, and the conversation it sparked among ordinary readers, reveals something deeper than any single historical dispute. It crystallizes a recurring pattern in American national-security and public-health policy: when a practice becomes politically or legally radioactive, the solution is often not to abandon it but to rename it.
The Biological Weapons Ban and Its Linguistic Cousin
The 1972 Biological Weapons Convention, which entered into force in 1975, prohibits the development, production, stockpiling, and use of biological and toxin weapons. The United States had already unilaterally renounced its offensive biological weapons program in 1969 under President Nixon. Offensive research aimed at weaponizing pathogens for military use is illegal under both treaty and domestic law.
What is not illegal—and what has been funded, regulated, paused, restarted, and restricted again over the past two decades—is a class of experiments known as gain-of-function research. In its broadest scientific sense, gain-of-function simply means modifying an organism so that it acquires a new property or enhances an existing one. Much of this work is routine and low-risk. The controversy centers on a narrower subset: experiments that deliberately increase the transmissibility, virulence, host range, or immune-evasion capacity of potential pandemic pathogens.
Defenders argue that such research helps scientists anticipate natural viral evolution, develop vaccines and therapeutics, and maintain readiness against emerging threats. Critics counter that the dual-use nature of the knowledge creates unacceptable risks of laboratory accidents or deliberate misuse, and that the same insights can often be obtained through safer methods. After high-profile lab incidents in 2014 and intense debate following the COVID-19 pandemic, successive administrations imposed funding pauses, layered review processes, and, most recently under a 2025 executive order and 2026 implementing policy, an explicit prohibition on federal funding for “dangerous gain-of-function” research defined by specific high-risk outcomes.
The linguistic move is precise. Work that would once have been described in the language of biological weapons research is now framed as “gain-of-function,” “pathogens with enhanced pandemic potential,” or “dual-use research of concern.” The new terminology carries the aura of pure science and public-health necessity. It also creates distance from the treaty-prohibited category of biological weapons.
The Precedent of “Enhanced Interrogation”
The pattern is familiar. After the September 11 attacks, the CIA developed a set of interrogation methods that included waterboarding, prolonged sleep deprivation, stress positions, and confinement in small spaces. Officials and lawyers insisted these were not torture. They were “enhanced interrogation techniques.” The distinction was presented as both legal and moral: the techniques had been carefully calibrated, approved by the Department of Justice, and were necessary to prevent further attacks.
John Kiriakou, a former CIA officer involved in the capture of Abu Zubaydah, became the first agency official to confirm publicly, in a 2007 ABC News interview, that waterboarding had been used and that he considered it torture. He was later prosecuted—not for revealing the existence of the program, but for disclosing the identity of a covert officer to a journalist. He pleaded guilty to one count under the Intelligence Identities Protection Act, was sentenced to 30 months in federal prison, lost his pension, incurred roughly a million dollars in legal debt, and faced years of financial and personal hardship. No one who authorized or conducted the waterboarding sessions faced criminal charges.
The parallel drawn in private conversations is blunt: “This is not biological weapons research. This is gain-of-function research.” “This is not torture. This is enhanced interrogation.” In both cases, the rebranding performed political and legal work. It allowed institutions to continue contested activities while claiming compliance with norms that would otherwise prohibit them. And in both cases, those who insisted on using the older, plainer language paid a personal price.
Why the Distinction Matters
Language is not merely cosmetic. It shapes oversight, funding eligibility, public accountability, and the threshold at which risk is deemed acceptable. When an activity is labeled “research,” institutional review boards, biosafety committees, and funding agencies apply scientific and risk-benefit frameworks. When the same activity is labeled a “biological weapon,” different legal regimes, verification mechanisms, and political constraints apply. The Biological Weapons Convention itself has long been criticized for lacking robust verification tools precisely because the dual-use nature of modern biology makes the boundary hard to police.
Recent policy changes—banning federal support for the highest-risk forms of gain-of-function work and tightening rules on international collaborations in countries of concern—acknowledge that the risks are real. Laboratory accidents involving high-consequence pathogens have occurred. The theoretical possibility of an engineered pathogen escaping and causing catastrophic loss of life is no longer dismissed as science fiction by serious policymakers. Yet the underlying tension remains: how societies govern research that sits on the knife-edge between legitimate scientific inquiry and existential hazard.
The Human Cost of Euphemism
The deeper danger of successive rebrandings is not only the possibility of laboratory escape or deliberate misuse. It is the gradual erosion of public trust and the normalization of practices that would once have been considered beyond the pale. When citizens watch authorities rename controversial programs rather than candidly debate their risks and benefits, skepticism becomes rational. When whistleblowers who use the older language are punished while the programs continue under new labels, the lesson is clear.
The tick-release claims, the gain-of-function debates, and the enhanced-interrogation episode are not identical. Historical military arthropod experiments, modern pathogen-enhancement studies, and post-9/11 interrogation practices occupy different legal, scientific, and moral domains. What they share is a pattern of linguistic engineering that distances official descriptions from the plain meanings ordinary people understand.
In an era of synthetic biology, artificial intelligence-assisted design of novel pathogens, and laboratory infrastructure scattered across the globe, the stakes of that linguistic distance are higher than ever. Clarity of language is not a stylistic preference. It is a prerequisite for democratic oversight of technologies that could, if mismanaged, reshape human civilization. The alternative—endless cycles of rebranding, containment failures, and after-the-fact justifications—is a risk no society can afford to treat as merely semantic.
0 Comments